Gary A. Lyons

Gary A. Lyons is recorded as Board Member at Neurocrine Biosciences Inc (NBIX) since January 1, 1993. The newest filing on record that lists Gary A. Lyons as Board Member at Neurocrine Biosciences Inc (NBIX) is dated April 15, 2026. Earlier roles on record: Board Member at Eledon Pharmaceuticals, Inc. (ELDN) until April 26, 2023. Neurocrine Biosciences Inc reported in an 8-K filed May 28, 2026 that Gary A. Lyons was appointed Class III Director, effective May 27, 2026. Neurocrine Biosciences Inc reported in an 8-K filed May 19, 2023 that Gary A. Lyons was appointed Class III Director, effective May 17, 2023. Eledon Pharmaceuticals, Inc. reported in an 8-K filed May 1, 2023 that Gary A. Lyons retired as Board of Directors, effective April 26, 2023. Neurocrine Biosciences Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Neurocrine Biosciences Inc includes Kevin Gorman (CEO and Board Member), Kyle Gano, Ph.D. (CEO and Board Member), Kyle W. Gano (CEO and Board Member) and 7 others.